“bevacizumab” Archives

in
Entry Author Date Location
Bio Roundup: Moderna Publishes, Life Science Cash, AdComm Votes & More 07/17/20 National
Bio Roundup: Eli Lilly Tries Tau, Generic Insulin, NASH Cash & More 12/14/18 National
Kodiak Sciences Files for IPO to Fund Global AMD Eye-Drug Studies 09/10/18 San Francisco
For More Lung Cancer Patients, the Promise of No Chemo Looms Larger 04/16/18 National
Merck Is Latest to Tout Success as Lung Cancer Drug Combos Plow Forward 01/16/18 New York
Bio Roundup: Trials to Watch, Mega Deals, Video Game Therapy & More 12/08/17 Boston
Bio Roundup: Migraine Data, Cancer Drug Combos, Azar Hearing & More 12/01/17 National
Lacking Details, Roche Touts Drug Combo’s Success in Lung Cancer 11/20/17 San Francisco
Gemini Reels In $42M to Target Root Causes of Age-Related Blindness 10/17/17 Boston
Bio Roundup: Phase 3 Fails, Shkreli Jailed, Moderna Flip-Flops & More 09/15/17 National
Ophthotech’s Final Try at Combo Eye Drug Comes up Short 08/14/17 New York
Waving White Flag, Cerulean Merges With Dare Bio, Sells Cancer Drugs 03/20/17 Boston
Another Notch For “PARP” Blockers As FDA Approves Clovis Cancer Drug 12/19/16 Boulder/Denver
After Setback, Ophthotech Restructures, Dials Down Eye Drug Studies 12/16/16 New York
Ophthotech Eye Drug Fails Badly in Pivotal Test, Shares Crumble 12/12/16 New York
On Front Lines Of Price Dispute, Eye Doctors Wary of New Drug Data 11/01/16 National
Duchenne Lessons: Advocates For Rare Spinal Disease Have Eyes on FDA 08/26/16 National
Cerulean’s Shares Routed as Cancer Drug Comes up Short Again 08/17/16 Boston
American Copycats: Can Biosimilars Catch On And Cut Costs In U.S.? 09/15/15 National
East Coast Biotech Roundup: Regeneron, Synergy, Foundation & More 07/31/15 Boston
The Near Death, and Second Life, of Cerulean Pharma 07/13/15 Boston
Celldex Builds Case for Brain Cancer Vaccine With New ASCO Data 05/31/15 New York
West Coast Biotech Roundup: Laguna, SeaGen, Unchained, DME & More 02/19/15 San Francisco
Celldex Touts Brain Cancer Vaccine Data, Talks FDA Strategy 11/14/14 New York
Military Strategies Being Used in the War on Cancer 08/04/14 Seattle
Avalanche Bio Rolls Onto Nasdaq After Upsized, $102M IPO 07/31/14 San Francisco
East Coast Biotech Roundup: Bristol, PTC, Ophthotech, & More 05/27/14 Boston
Ophthotech, Novartis Team up on $1B Deal for Eye Drug 05/19/14 New York
Kala Pharma Grabs $22.5M More For Eye Drugs 04/23/14 Boston
Cerulean Limps into Nasdaq Debut With $7 Per Share IPO 04/10/14 Boston
Page 1 of 2 next page »